D-dimer Levels in Stable COPD Patients: A Case-control Study

REFERENCES

• Barnes PJ. Chronic obstructive pulmonary disease. N Engl J Med 2000; 343(4): 269–280.
   PubMed Web of Science ®Google Scholar
• Stone AC, Nici L. Other systemic manifestations of chronic obstructive pulmonary disease. Clin Chest Med 2007; 28(3):553–557, vi.
   PubMed Web of Science ®Google Scholar
• Esmon CT Does inflammation contribute to thrombotic events? Haemostasis 2000; 30 Suppl 2:34–40.
   PubMedGoogle Scholar
• Libby P, Simon DI. Inflammation and thrombosis: the clot thickens. Circulation 2001; 103(13):1718–1720.
   PubMed Web of Science ®Google Scholar
• Akgun M, Meral M, Onbas O, Araz O, Koplay M, Aslan S, Mirici A. Comparison of clinical characteristics and outcomes of patients with COPD exacerbation with or without venous thromboembolism. Respiration 2006; 73(4):428–433.
   PubMed Web of Science ®Google Scholar
• Karwat K, Kosciuch J, Chazan R. (Is microembolism present and is it important element of COPD exacerbation?). Pol Merkur Lekarski 2005; 18(106):385–388.
   PubMedGoogle Scholar
• Sohne M, Kruip MJ, Nijkeuter M, Tick L, Kwakkel H, Halkes SJ, Accuracy of clinical decision rule, D-dimer and spiral computed tomography in patients with malignancy, previous venous thromboembolism, COPD or heart failure and in older patients with suspected pulmonary embolism. J Thromb Haemost 2006; 4(5):1042–1046.
   PubMed Web of Science ®Google Scholar
• Hartmann IJ, Hagen PJ, Melissant CF, Postmus PE, Prins MH. Diagnosing acute pulmonary embolism: effect of chronic obstructive pulmonary disease on the performance of D-dimer testing, ventilation/perfusion scintigraphy, spiral computed tomographic angiography, and conventional angiography. ANTELOPE Study Group. Advances in New Technologies Evaluating the Localization of Pulmonary Embolism. Am J Respir Crit Care Med 2000; 162(6):2232–2237.
   PubMed Web of Science ®Google Scholar
• Alessandri C, Basili S, Violi F, Ferroni P, Gazzaniga PP, Cordova C. Hypercoagulability state in patients with chronic obstructive pulmonary disease. Chronic Obstructive Bronchitis and Haemostasis Group. Thromb Haemost 1994; 72(3):343–346.
   PubMed Web of Science ®Google Scholar
• Ashitani J, Mukae H, Arimura Y, Matsukura S. Elevated plasma procoagulant and fibrinolytic markers in patients with chronic obstructive pulmonary disease. Intern Med 2002; 41(3):181–185.
   PubMed Web of Science ®Google Scholar
• Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176(6):532–555.
   PubMed Web of Science ®Google Scholar
• MacIntyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, Brusasco V Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005; 26(4):720–735.
   PubMed Web of Science ®Google Scholar
• Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A Standardisation of spirometry. Eur Respir J 2005; 26(2):319–338.
   PubMed Web of Science ®Google Scholar
• Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F Standardisation of the measurement of lung volumes. Eur Respir J 2005; 26(3):511–522.
   PubMed Web of Science ®Google Scholar
• Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981; 123(6): 659–664.
   PubMed Web of Science ®Google Scholar
• Crapo RO, Morris AH. Standardized single breath normal values for carbon monoxide diffusing capacity. Am Rev Respir Dis 1981; 123(2):185–189.
   PubMed Web of Science ®Google Scholar
• Crapo RO, Morris AH, Clayton PD, Nixon CR. Lung volumes in healthy nonsmoking adults. Bull Eur Physiopathol Respir 1982; 18(3):419–425.
   PubMedGoogle Scholar
• Ginsberg JS, Wells PS, Brill-Edwards P, Donovan D, Panju A, van Beek EJ, Patel A. Application of a novel and rapid whole blood assay for D-dimer in patients with clinically suspected pulmonary embolism. Thromb Haemost 1995; 73(1):35–38.
   PubMed Web of Science ®Google Scholar
• Raimondi P, Bongard O, de MP, Reber G, Waldvogel F, Bounameaux H. D-dimer plasma concentration in various clinical conditions: implication for the use of this test in the diagnostic approach of venous thromboembolism. Thromb Res 1993; 69(1):125–130.
   PubMed Web of Science ®Google Scholar
• Aibar M, Laborda K, Conget F, Cornudella R. Hipercoagulability state and endotelial injury in stable chronic obstructive pulmonary disease patients. An Sist Sanit Navar 2010; 33:43–50.
   PubMed Web of Science ®Google Scholar
• Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004; 59(7): 574–580.
   PubMed Web of Science ®Google Scholar
• Papaioannou AI, Mazioti A, Kiropoulos T, Tsilioni I, Koutsokera A, Tanou K, Systemic and airway inflammation and the presence of emphysema in patients with COPD. Respir Med 2010; 104(2):275–282.
   PubMed Web of Science ®Google Scholar
• Engstrom G, Lind P, Hedblad B, Wollmer P, Stavenow L, Janzon L, Lindgarde F. Lung function and cardiovascular risk: relationship with inflammation-sensitive plasma proteins. Circulation 2002; 106(20):2555–2560.
   PubMed Web of Science ®Google Scholar
• Thyagarajan B, Jacobs DR, Apostol GG, Smith LJ, Lewis CE, Williams OD. Plasma fibrinogen and lung function: the CARDIA Study. Int J Epidemiol 2006; 35(4):1001–1008.
   PubMed Web of Science ®Google Scholar
• Garcia-Rio F, Miravitlles M, Soriano JB, Munoz L, Duran-Tauleria E, Sanchez G, Systemic inflammation in chronic obstructive pulmonary disease: a population-based study. Respir Res 2010;11:63.
   PubMed Web of Science ®Google Scholar
• Sin DD, Man SF, Marciniuk DD, Ford G, FitzGerald M, Wong E, The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 177(11):1207–1214.
   PubMed Web of Science ®Google Scholar
• Lijnen HR. Role of fibrinolysis in obesity and thrombosis. Thromb Res 2009; 123 Suppl 4: S46–S49.
   Google Scholar
• Abdollahi M, Cushman M, Rosendaal FR. Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use. Thromb Haemost 2003; 89(3):493–498.
   PubMed Web of Science ®Google Scholar
• Cushman M, Folsom AR, Wang L, Aleksic N, Rosamond WD, Tracy RP, Heckbert SR. Fibrin fragment D-dimer and the risk of future venous thrombosis. Blood 2003; 101(4):1243–1248.
   PubMed Web of Science ®Google Scholar
• Goldhaber SZ, Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Speizer FE, A prospective study of risk factors for pulmonary embolism in women. JAMA 1997; 277(8):642–645.
   PubMed Web of Science ®Google Scholar
• Hansson PO, Eriksson H, Welin L, Svardsudd K, Wilhelmsen L. Smoking and abdominal obesity: risk factors for venous thromboembolism among middle-aged men: “the study of men born in 1913”. Arch Intern Med 1999; 159(16):1886–1890.
   PubMed Web of Science ®Google Scholar
• Pomp ER, le CS, Rosendaal FR, Doggen CJ. Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations. Br J Haematol 2007; 139(2):289–296.
   PubMed Web of Science ®Google Scholar
• Wannamethee SG, Tchernova J, Whincup P, Lowe GD, Kelly A, Rumley A, Plasma leptin: associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease. Atherosclerosis 2007; 191(2):418–426.
   PubMed Web of Science ®Google Scholar
• Corsonello A, Antonelli Incalzi R, Pistelli R, Pedone C, Bustacchini S, Lattanzio F. Comorbidities of chronic obstructive pulmonary disease. Curr Opin Pulm Med 201; 17(Suppl 1):S21–28.
   Google Scholar
• Nussbaumer-Ochsner Y, Rabe KF. Systemic manifestations of COPD. Chest 2011; 139(1):165–173.
   PubMed Web of Science ®Google Scholar